From the pathological point of view, PTTG1 has been found to be expressed at high levels in human pituitary adenomas and other malignant tumors including breast, lung, prostate, ovary and thyroid cancer, as well as in haematopoietic neoplasias [9-15]. Here, PTTG1 is linked to cancer.